122 related articles for article (PubMed ID: 38365314)
1. AmpFire HPV and ScreenFire RS HPV validation trial.
Hou J; Belinson JL; Du H; Li C; Zhang W; Zhang L; Zhang Y; Qu X; Wu R
Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38365314
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi.
Mungo C; Guliam A; Chinula L; Inturrisi F; Msowoya L; Mkochi T; Jawadu S; de Sanjosé S; Schiffman M; Tang JH; Smith JS
Infect Agent Cancer; 2024 May; 19(1):24. PubMed ID: 38760798
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi.
Mungo C; Guliam A; Chinula L; Inturrisi F; Msowoya L; Mkochi T; Jawadu S; de Sanjosé S; Schiffman M; Tang JH; Smith JS
medRxiv; 2024 Feb; ():. PubMed ID: 38617305
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening.
Zhang W; Du H; Huang X; Wang C; Duan X; Liu Y; Shi B; Zhang W; Qu X; Wei L; Schiffman M; Belinson JL; Wu R
Infect Agent Cancer; 2020; 15():65. PubMed ID: 33110442
[TBL] [Abstract][Full Text] [Related]
5. Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.
Desai KT; Adepiti CA; Schiffman M; Egemen D; Gage JC; Wentzensen N; de Sanjose S; Burk RD; Ajenifuja KO
Int J Cancer; 2022 Oct; 151(7):1142-1149. PubMed ID: 35666530
[TBL] [Abstract][Full Text] [Related]
6. A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
Inturrisi F; de Sanjosé S; Desai KT; Dagnall C; Egemen D; Befano B; Rodriguez AC; Jeronimo JA; Zuna RE; Hoffman A; Farhat Nozzari S; Walker JL; Perkins RB; Wentzensen N; Palefsky JM; Schiffman M
Int J Cancer; 2024 Jan; 154(2):241-250. PubMed ID: 37772799
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results.
Zhang Y; Zhang W; Du H; Qu X; Chen Y; Wang J; Wu R
BMC Infect Dis; 2023 Nov; 23(1):783. PubMed ID: 37950154
[TBL] [Abstract][Full Text] [Related]
8. Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda.
Murangwa A; Desai KT; Gage JC; Murenzi G; Tuyisenge P; Kanyabwisha F; Musafili A; Kubwimana G; Mutesa L; Anastos K; Kim HY; Castle PE
Afr J Lab Med; 2022; 11(1):1827. PubMed ID: 36353194
[TBL] [Abstract][Full Text] [Related]
9. Comparison of AmpFire and MY09/11 assays for HPV genotyping in anogenital specimen of Rwandan men who have sex with men.
Kanyabwisha F; Kim HY; Shi Q; Murenzi G; Tuyisenge P; Kubwimana G; Munyaneza A; Murangwa A; Turizigiye O; Da Costa M; Nsengiyumva B; Chen X; Mutesa L; Anastos KM; Palefsky JM
Heliyon; 2023 May; 9(5):e16016. PubMed ID: 37305475
[TBL] [Abstract][Full Text] [Related]
10. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
Stanczuk G; Baxter G; Currie H; Lawrence J; Cuschieri K; Wilson A; Arbyn M
BMJ Open; 2016 Apr; 6(4):e010660. PubMed ID: 27113237
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Dhillon SK; Cocuzza CE; Chung PYJ; Martinelli M; Giubbi C; Njoku RC; Bhatia R; Cuschieri K; Arbyn M
J Med Virol; 2023 Jan; 95(1):e28417. PubMed ID: 36541733
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
13. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
[TBL] [Abstract][Full Text] [Related]
14. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
15. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
[TBL] [Abstract][Full Text] [Related]
17. Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.
Fu Y; Li X; Li Y; Lu W; Xie X; Wang X
Microbiol Spectr; 2022 Feb; 10(1):e0157021. PubMed ID: 35171029
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation.
Moyo S; Ramogola-Masire D; Moraka NO; Tawe L; Noubary F; Motsumi K; Manowe G; Zuze B; Radibe B; Hungwe FTT; Mohammed T; Maphorisa C; Shapiro R; Gaseitsiwe S; Luckett R
Infect Agent Cancer; 2023 May; 18(1):29. PubMed ID: 37165397
[TBL] [Abstract][Full Text] [Related]
19. Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).
Cuschieri K; Geraets D; Cuzick J; Cadman L; Moore C; Vanden Broeck D; Padalko E; Quint W; Arbyn M
J Clin Microbiol; 2016 Sep; 54(9):2337-42. PubMed ID: 27385707
[TBL] [Abstract][Full Text] [Related]
20. Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.
Zhang Y; Du H; Xiao A; Zhang W; Wang C; Huang X; Qu X; Wang J; Wu R
Infect Agent Cancer; 2022 Jun; 17(1):27. PubMed ID: 35690793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
